Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
publication:juan [2019/03/09 03:52]
游文萱
publication:juan [2019/03/13 09:05] (current)
游文萱
Line 5: Line 5:
   - Yang, T.-W., Sahu, D., Chang, Y.-W., Hsu, C.-L., Hsieh, C.-H., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) “RNA-binding proteomics reveals MATR3 interacting with lncRNA SNHG1 to enhance neuroblastoma progression” //Journal of Proteome Research// 18: 406–416.   - Yang, T.-W., Sahu, D., Chang, Y.-W., Hsu, C.-L., Hsieh, C.-H., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) “RNA-binding proteomics reveals MATR3 interacting with lncRNA SNHG1 to enhance neuroblastoma progression” //Journal of Proteome Research// 18: 406–416.
   - Chang, J.-Y., Yu, W.-H., __**Juan, H.-F.**__*, Huang, H.-C.* (2018) "​Dynamics of alternative polyadenylation in human preimplantation embryos"​ //​Biochemical and Biophysical Research// Sep 11. pii: S0006-291X(18)31946-6.   - Chang, J.-Y., Yu, W.-H., __**Juan, H.-F.**__*, Huang, H.-C.* (2018) "​Dynamics of alternative polyadenylation in human preimplantation embryos"​ //​Biochemical and Biophysical Research// Sep 11. pii: S0006-291X(18)31946-6.
-  - Huang, C.-T., Hsieh, C.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2018) "A large-scale gene expression intensity-based similarity metric for drug repositioning"​ //iSciecne// 7: 40-52. (Cell Press)+  - Huang, C.-T., Hsieh, C.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2018) "A large-scale gene expression intensity-based similarity metric for drug repositioning"​ //iScience// 7: 40-52. (Cell Press)
   - Lin, M.-C., Chien, P.-H., Wu, H.-Y., Chen, S.-T., __**Juan, H.-F.**__, Lou, P.-J.*, Huang, M.-C. (2018) "​C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer"​ //​Oncogene//​ Jun 21. doi: 10.1038/​s41388-018-0375-0.   - Lin, M.-C., Chien, P.-H., Wu, H.-Y., Chen, S.-T., __**Juan, H.-F.**__, Lou, P.-J.*, Huang, M.-C. (2018) "​C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer"​ //​Oncogene//​ Jun 21. doi: 10.1038/​s41388-018-0375-0.
   - Sahu, D., Ho, S.-Y., __**Juan, H.-F.**__*, Huang, H.-C.* (2018) "​High-risk,​ expression-based prognostic long noncoding RNA signature in neuroblastoma"​ //JNCI Cancer Spectrum// 2(2): pky015.   - Sahu, D., Ho, S.-Y., __**Juan, H.-F.**__*, Huang, H.-C.* (2018) "​High-risk,​ expression-based prognostic long noncoding RNA signature in neuroblastoma"​ //JNCI Cancer Spectrum// 2(2): pky015.